tiprankstipranks
Trending News
More News >
Fusion Antibodies Plc (GB:FAB)
:FAB
UK Market

Fusion Antibodies Plc (FAB) Income Statement

Compare
8 Followers

Fusion Antibodies Plc Income Statement

Last quarter (Q2 2025), Fusion Antibodies Plc's total revenue was £838.00K, an increase of 54.90% from the same quarter last year. In Q2, Fusion Antibodies Plc's net income was £-512.00K. See Fusion Antibodies Plc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
£ 1.97M£ 1.14M£ 2.90M£ 4.80M£ 4.17M
Gross Profit
£ 430.00K£ -265.00K£ 202.00K£ 1.72M£ 1.31M
Operating Expenses
£ 2.21M£ 2.24M£ 3.04M£ 3.05M£ 2.69M
Depreciation and Amortization
£ 102.00K£ 219.00K£ 372.00K£ 751.00K£ 714.00K
EBITDA
£ -1.62M£ -2.06M£ -2.48M£ -573.00K£ -532.00K
Operating Income
£ -1.78M£ -2.29M£ -2.83M£ -1.33M£ -1.38M
Other Income/Expenses
£ 2.00K£ -1.00K£ -1.00K£ -8.00K£ -15.00K
Pretax Income
£ -1.78M£ -2.29M£ -2.86M£ -1.33M£ -1.26M
Net Income
£ -1.71M£ -2.23M£ -2.60M£ -1.20M£ -2.90M
Per Share Metrics
Basic EPS
£ -0.02£ -0.04£ -0.10£ -0.05£ -0.11
Diluted EPS
£ -0.02£ -0.04£ -0.10£ -0.05£ -0.11
Weighted Average Shares Outstanding
95.88M 55.56M 26.01M 25.95M 25.46M
Weighted Average Shares Outstanding (Diluted)
95.88M 55.56M 26.01M 25.95M 25.46M
Currency in GBP

Fusion Antibodies Plc Earnings and Revenue History